Novel active stealth micelles based on β₂M achieved effective antitumor therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Micelles are investigated for antitumor drug delivery due to their favorable characteristics.
• Phagocytic clearance by the mononuclear phagocyte system limits micelle circulation and tumor accumulation.
• Beta2-microglobulin (β2M) exhibits antiphagocytic properties relevant for biomaterial functionalization.

Purpose of the Study:

• To develop β2M-derived peptide-functionalized micelles with antiphagocytic and drug-responsive properties.
• To enhance micelle circulation time and tumor-specific drug delivery for improved cancer therapy.

Main Methods:

• Surface functionalization of poly(ethylene glycol)-b-poly(caprolactone) (PEG-PCL) micelles with a dual-functional peptide.
• The peptide integrates a β2M-derived sequence and a matrix metalloproteinase-2 (MMP-2) cleavable sequence.
• Evaluation of micelle phagocytosis, tumor accumulation, and therapeutic efficacy in vitro and in vivo.

Main Results:

• Micelles modified with the dual-functional peptide demonstrated reduced phagocytosis by macrophages.
• Enhanced internalization by tumor-associated macrophages was observed in the presence of MMP-2.
• Increased tumor accumulation of loaded photosensitizers and improved antitumor therapy were achieved.

Conclusions:

• Antiphagocytic peptides derived from endogenous proteins are effective for micelle surface modification.
• Dual-functional peptide-modified micelles offer a promising strategy for smart drug delivery and enhanced cancer treatment.
• This approach overcomes limitations of phagocytic clearance, improving drug delivery to tumors.